https://newdrugapprovals.org/2026/07/22/gedatolisib/New Drug Approvalsen2026-07-22T02:43:02+00:00GedatolisibPHASE 3, PFIZER, Antitumor agent, PF 05212384, PF 5212384, PKI-587, PF-05212384; PF-5212384; PKI 587, gedatolisib, гедатолисиб, غيداتوليسيب, 吉达利塞, FDA 2026, anax labs, approvals 3026